Advertisement

Index by Author

September 1988; 37 (9)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abe, N

    • Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic rats. Diabetes September 1988 37:1181-1187; doi:10.2337/diabetes.37.9.1181

  2. Akiyama, N

    • Alteration of 1,2-diacylglycerol content in myocardium from diabetic rats. Diabetes September 1988 37:1168-1172; doi:10.2337/diabetes.37.9.1168

  3. Almira, E C

    • Inhibition of insulin-stimulated glucose transport by factor extracted from serum of insulin-resistant patient. Diabetes September 1988 37:1217-1225; doi:10.2337/diabetes.37.9.1217

  4. Alvarez, I M

    • Inhibition of insulin-stimulated glucose transport by factor extracted from serum of insulin-resistant patient. Diabetes September 1988 37:1217-1225; doi:10.2337/diabetes.37.9.1217

  5. Amatruda, J M

    • Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes. Diabetes September 1988 37:1234-1240; doi:10.2337/diabetes.37.9.1234

B

  1. Baba, S

    • Secretin-induced exocrine secretion in perfused pancreas isolated from diabetic rats. Diabetes September 1988 37:1173-1180; doi:10.2337/diabetes.37.9.1173

  2. Baird, J D

    • Distinct macrophage subpopulations in pancreas of prediabetic BB/E rats. Possible role for macrophages in pathogenesis of IDDM. Diabetes September 1988 37:1301-1304; doi:10.2337/diabetes.37.9.1301

  3. Barbosa, J J

    • Long-term follow-up of polyneuropathy in diabetic kidney transplant recipients. Diabetes September 1988 37:1247-1252; doi:10.2337/diabetes.37.9.1247

  4. Bertrand, J

    • Structure, function, and immunogenicity of human insulinoma cells. Diabetes September 1988 37:1279-1286; doi:10.2337/diabetes.37.9.1279

  5. Boden, G

    • Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes September 1988 37:1212-1216; doi:10.2337/diabetes.37.9.1212

  6. Bolognino, M

    • Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes. Diabetes September 1988 37:1234-1240; doi:10.2337/diabetes.37.9.1234

  7. Bone, A J

    • Distinct macrophage subpopulations in pancreas of prediabetic BB/E rats. Possible role for macrophages in pathogenesis of IDDM. Diabetes September 1988 37:1301-1304; doi:10.2337/diabetes.37.9.1301

C

  1. Caro, J F

    • Inhibition of insulin-stimulated glucose transport by factor extracted from serum of insulin-resistant patient. Diabetes September 1988 37:1217-1225; doi:10.2337/diabetes.37.9.1217

  2. Cochrane, C

    • Diet-induced type II diabetes in C57BL/6J mice. Diabetes September 1988 37:1163-1167; doi:10.2337/diabetes.37.9.1163

  3. Coleman, D L

    • Genetic control of organ-reactive autoantibody production in mice by obesity (ob) diabetes (db) genes. Diabetes September 1988 37:1287-1293; doi:10.2337/diabetes.37.9.1287

  4. Cooke, A

    • Distinct macrophage subpopulations in pancreas of prediabetic BB/E rats. Possible role for macrophages in pathogenesis of IDDM. Diabetes September 1988 37:1301-1304; doi:10.2337/diabetes.37.9.1301

  5. Cozzolino, D

    • Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent. Diabetes September 1988 37:1265-1270; doi:10.2337/diabetes.37.9.1265

D

  1. D'Onofrio, F

    • Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent. Diabetes September 1988 37:1265-1270; doi:10.2337/diabetes.37.9.1265

  2. Dandona, P

    • Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial. Diabetes September 1988 37:1260-1264; doi:10.2337/diabetes.37.9.1260

  3. Demidem, A

    • Structure, function, and immunogenicity of human insulinoma cells. Diabetes September 1988 37:1279-1286; doi:10.2337/diabetes.37.9.1279

  4. Dohm, G L

    • Inhibition of insulin-stimulated glucose transport by factor extracted from serum of insulin-resistant patient. Diabetes September 1988 37:1217-1225; doi:10.2337/diabetes.37.9.1217

  5. Dunning, B E

    • Galanin--sympathetic neurotransmitter in endocrine pancreas? Diabetes September 1988 37:1157-1162; doi:10.2337/diabetes.37.9.1157

  6. Durand, A

    • Structure, function, and immunogenicity of human insulinoma cells. Diabetes September 1988 37:1279-1286; doi:10.2337/diabetes.37.9.1279

F

  1. Feinglos, M N

    • Diet-induced type II diabetes in C57BL/6J mice. Diabetes September 1988 37:1163-1167; doi:10.2337/diabetes.37.9.1163

  2. Formby, B

    • Adoptive immunotherapy of diabetes in autologous nonobese diabetic mice with lymphoid cells ex vivo exposed to cyclosporin plus interleukin 2. Diabetes September 1988 37:1305-1309; doi:10.2337/diabetes.37.9.1305

G

  1. Galloway, J A

    • Reevaluation of urine C-peptide as measure of insulin secretion. Diabetes September 1988 37:1195-1201; doi:10.2337/diabetes.37.9.1195

  2. Giroix, M H

    • Insulin production and glucose metabolism in isolated pancreatic islets of rats with NIDDM. Diabetes September 1988 37:1226-1233; doi:10.2337/diabetes.37.9.1226

  3. Gisinger, C

    • Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial. Diabetes September 1988 37:1260-1264; doi:10.2337/diabetes.37.9.1260

  4. Giugliano, D

    • Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent. Diabetes September 1988 37:1265-1270; doi:10.2337/diabetes.37.9.1265

  5. Given, B D

    • Reevaluation of urine C-peptide as measure of insulin secretion. Diabetes September 1988 37:1195-1201; doi:10.2337/diabetes.37.9.1195

  6. Goetz, F C

    • Long-term follow-up of polyneuropathy in diabetic kidney transplant recipients. Diabetes September 1988 37:1247-1252; doi:10.2337/diabetes.37.9.1247

  7. Goldfine, I D

    • Sequence and analysis of promoter region of human insulin-receptor gene. Diabetes September 1988 37:1241-1246; doi:10.2337/diabetes.37.9.1241

  8. Goto, Y

    • Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes September 1988 37:1188-1194; doi:10.2337/diabetes.37.9.1188

  9. Green, A

    • Inhibition of insulin-stimulated glucose transport by factor extracted from serum of insulin-resistant patient. Diabetes September 1988 37:1217-1225; doi:10.2337/diabetes.37.9.1217

H

  1. Haftek, M

    • Structure, function, and immunogenicity of human insulinoma cells. Diabetes September 1988 37:1279-1286; doi:10.2337/diabetes.37.9.1279

  2. Hasdai, D

    • Effect of hyperglycemia on pain perception and on efficacy of morphine analgesia in rats. Diabetes September 1988 37:1253-1259; doi:10.2337/diabetes.37.9.1253

  3. Hashimoto, H

    • Alteration of 1,2-diacylglycerol content in myocardium from diabetic rats. Diabetes September 1988 37:1168-1172; doi:10.2337/diabetes.37.9.1168

  4. Hellerström, C

    • Insulin production and glucose metabolism in isolated pancreatic islets of rats with NIDDM. Diabetes September 1988 37:1226-1233; doi:10.2337/diabetes.37.9.1226

J

  1. Jackson, T K

    • Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes. Diabetes September 1988 37:1234-1240; doi:10.2337/diabetes.37.9.1234

  2. Jeremy, J

    • Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial. Diabetes September 1988 37:1260-1264; doi:10.2337/diabetes.37.9.1260

K

  1. Kashiwagi, A

    • Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic rats. Diabetes September 1988 37:1181-1187; doi:10.2337/diabetes.37.9.1181

  2. Kennedy, W R

    • Long-term follow-up of polyneuropathy in diabetic kidney transplant recipients. Diabetes September 1988 37:1247-1252; doi:10.2337/diabetes.37.9.1247

  3. Kida, Y

    • Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic rats. Diabetes September 1988 37:1181-1187; doi:10.2337/diabetes.37.9.1181

  4. Kim, M K

    • Genetic control of organ-reactive autoantibody production in mice by obesity (ob) diabetes (db) genes. Diabetes September 1988 37:1287-1293; doi:10.2337/diabetes.37.9.1287

  5. Kodama, M

    • Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic rats. Diabetes September 1988 37:1181-1187; doi:10.2337/diabetes.37.9.1181

  6. Kuhn, C M

    • Diet-induced type II diabetes in C57BL/6J mice. Diabetes September 1988 37:1163-1167; doi:10.2337/diabetes.37.9.1163

L

  1. Leiter, E H

    • Genetic control of organ-reactive autoantibody production in mice by obesity (ob) diabetes (db) genes. Diabetes September 1988 37:1287-1293; doi:10.2337/diabetes.37.9.1287

M

  1. Maddux, B A

    • Sequence and analysis of promoter region of human insulin-receptor gene. Diabetes September 1988 37:1241-1246; doi:10.2337/diabetes.37.9.1241

  2. Malaisse, W J

    • Insulin production and glucose metabolism in isolated pancreatic islets of rats with NIDDM. Diabetes September 1988 37:1226-1233; doi:10.2337/diabetes.37.9.1226

  3. Mamula, P W

    • Sequence and analysis of promoter region of human insulin-receptor gene. Diabetes September 1988 37:1241-1246; doi:10.2337/diabetes.37.9.1241

  4. McArthur, R G

    • Genetic control of organ-reactive autoantibody production in mice by obesity (ob) diabetes (db) genes. Diabetes September 1988 37:1287-1293; doi:10.2337/diabetes.37.9.1287

  5. McCubbin, J A

    • Diet-induced type II diabetes in C57BL/6J mice. Diabetes September 1988 37:1163-1167; doi:10.2337/diabetes.37.9.1163

  6. McDonald, A R

    • Sequence and analysis of promoter region of human insulin-receptor gene. Diabetes September 1988 37:1241-1246; doi:10.2337/diabetes.37.9.1241

  7. Melmed, R N

    • Effect of hyperglycemia on pain perception and on efficacy of morphine analgesia in rats. Diabetes September 1988 37:1253-1259; doi:10.2337/diabetes.37.9.1253

  8. Mikhailidis, D

    • Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial. Diabetes September 1988 37:1260-1264; doi:10.2337/diabetes.37.9.1260

  9. Miller, N

    • Adoptive immunotherapy of diabetes in autologous nonobese diabetic mice with lymphoid cells ex vivo exposed to cyclosporin plus interleukin 2. Diabetes September 1988 37:1305-1309; doi:10.2337/diabetes.37.9.1305

  10. Misbin, R I

    • Inhibition of insulin-stimulated glucose transport by factor extracted from serum of insulin-resistant patient. Diabetes September 1988 37:1217-1225; doi:10.2337/diabetes.37.9.1217

  11. Myers, B D

    • Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes September 1988 37:1202-1211; doi:10.2337/diabetes.37.9.1202

N

  1. Najarian, J S

    • Long-term follow-up of polyneuropathy in diabetic kidney transplant recipients. Diabetes September 1988 37:1247-1252; doi:10.2337/diabetes.37.9.1247

  2. Nakamura, T

    • Secretin-induced exocrine secretion in perfused pancreas isolated from diabetic rats. Diabetes September 1988 37:1173-1180; doi:10.2337/diabetes.37.9.1173

  3. Nakamura, Y

    • Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes September 1988 37:1202-1211; doi:10.2337/diabetes.37.9.1202

  4. Navarro, X

    • Long-term follow-up of polyneuropathy in diabetic kidney transplant recipients. Diabetes September 1988 37:1247-1252; doi:10.2337/diabetes.37.9.1247

  5. Nishio, Y

    • Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic rats. Diabetes September 1988 37:1181-1187; doi:10.2337/diabetes.37.9.1181

  6. Nobunaga, T

    • Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes September 1988 37:1188-1194; doi:10.2337/diabetes.37.9.1188

O

  1. Ogawa, K

    • Alteration of 1,2-diacylglycerol content in myocardium from diabetic rats. Diabetes September 1988 37:1168-1172; doi:10.2337/diabetes.37.9.1168

  2. Ohki, A

    • Secretin-induced exocrine secretion in perfused pancreas isolated from diabetic rats. Diabetes September 1988 37:1173-1180; doi:10.2337/diabetes.37.9.1173

  3. Okabayashi, Y

    • Secretin-induced exocrine secretion in perfused pancreas isolated from diabetic rats. Diabetes September 1988 37:1173-1180; doi:10.2337/diabetes.37.9.1173

  4. Okumura, K

    • Alteration of 1,2-diacylglycerol content in myocardium from diabetic rats. Diabetes September 1988 37:1168-1172; doi:10.2337/diabetes.37.9.1168

  5. Otsuki, M

    • Secretin-induced exocrine secretion in perfused pancreas isolated from diabetic rats. Diabetes September 1988 37:1173-1180; doi:10.2337/diabetes.37.9.1173

  6. Owen, O E

    • Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes September 1988 37:1212-1216; doi:10.2337/diabetes.37.9.1212

  7. Oya, K

    • Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes September 1988 37:1188-1194; doi:10.2337/diabetes.37.9.1188

P

  1. Pak, C Y

    • Genetic control of organ-reactive autoantibody production in mice by obesity (ob) diabetes (db) genes. Diabetes September 1988 37:1287-1293; doi:10.2337/diabetes.37.9.1287

  2. Peterson, C M

    • Adoptive immunotherapy of diabetes in autologous nonobese diabetic mice with lymphoid cells ex vivo exposed to cyclosporin plus interleukin 2. Diabetes September 1988 37:1305-1309; doi:10.2337/diabetes.37.9.1305

  3. Polonsky, K S

    • Reevaluation of urine C-peptide as measure of insulin secretion. Diabetes September 1988 37:1195-1201; doi:10.2337/diabetes.37.9.1195

  4. Portha, B

    • Insulin production and glucose metabolism in isolated pancreatic islets of rats with NIDDM. Diabetes September 1988 37:1226-1233; doi:10.2337/diabetes.37.9.1226

R

  1. Raz, I

    • Effect of hyperglycemia on pain perception and on efficacy of morphine analgesia in rats. Diabetes September 1988 37:1253-1259; doi:10.2337/diabetes.37.9.1253

  2. Roncari, D A

    • Genetic control of organ-reactive autoantibody production in mice by obesity (ob) diabetes (db) genes. Diabetes September 1988 37:1287-1293; doi:10.2337/diabetes.37.9.1287

  3. Rubenstein, A H

    • Reevaluation of urine C-peptide as measure of insulin secretion. Diabetes September 1988 37:1195-1201; doi:10.2337/diabetes.37.9.1195

  4. Rue, P

    • Reevaluation of urine C-peptide as measure of insulin secretion. Diabetes September 1988 37:1195-1201; doi:10.2337/diabetes.37.9.1195

S

  1. Saeki, Y

    • Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic rats. Diabetes September 1988 37:1181-1187; doi:10.2337/diabetes.37.9.1181

  2. Salhanick, A I

    • Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes. Diabetes September 1988 37:1234-1240; doi:10.2337/diabetes.37.9.1234

  3. Salvatore, T

    • Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent. Diabetes September 1988 37:1265-1270; doi:10.2337/diabetes.37.9.1265

  4. Satake, T

    • Alteration of 1,2-diacylglycerol content in myocardium from diabetic rats. Diabetes September 1988 37:1168-1172; doi:10.2337/diabetes.37.9.1168

  5. Satoh, J

    • Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes September 1988 37:1188-1194; doi:10.2337/diabetes.37.9.1188

  6. Schernthaner, G

    • Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial. Diabetes September 1988 37:1260-1264; doi:10.2337/diabetes.37.9.1260

  7. Seltzer, Z

    • Effect of hyperglycemia on pain perception and on efficacy of morphine analgesia in rats. Diabetes September 1988 37:1253-1259; doi:10.2337/diabetes.37.9.1253

  8. Sener, A

    • Insulin production and glucose metabolism in isolated pancreatic islets of rats with NIDDM. Diabetes September 1988 37:1226-1233; doi:10.2337/diabetes.37.9.1226

  9. Serradas, P

    • Insulin production and glucose metabolism in isolated pancreatic islets of rats with NIDDM. Diabetes September 1988 37:1226-1233; doi:10.2337/diabetes.37.9.1226

  10. Shapiro, E T

    • Reevaluation of urine C-peptide as measure of insulin secretion. Diabetes September 1988 37:1195-1201; doi:10.2337/diabetes.37.9.1195

  11. Shigeta, Y

    • Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic rats. Diabetes September 1988 37:1181-1187; doi:10.2337/diabetes.37.9.1181

  12. Shintani, S

    • Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes September 1988 37:1188-1194; doi:10.2337/diabetes.37.9.1188

  13. Sparks, C E

    • Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes. Diabetes September 1988 37:1234-1240; doi:10.2337/diabetes.37.9.1234

  14. Sparks, J D

    • Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes. Diabetes September 1988 37:1234-1240; doi:10.2337/diabetes.37.9.1234

  15. Speiser, P

    • Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial. Diabetes September 1988 37:1260-1264; doi:10.2337/diabetes.37.9.1260

  16. Surwit, R S

    • Diet-induced type II diabetes in C57BL/6J mice. Diabetes September 1988 37:1163-1167; doi:10.2337/diabetes.37.9.1163

  17. Sutherland, D E

    • Long-term follow-up of polyneuropathy in diabetic kidney transplant recipients. Diabetes September 1988 37:1247-1252; doi:10.2337/diabetes.37.9.1247

T

  1. Taborsky, G J, Jr

    • Galanin--sympathetic neurotransmitter in endocrine pancreas? Diabetes September 1988 37:1157-1162; doi:10.2337/diabetes.37.9.1157

  2. Tanaka, S

    • Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes September 1988 37:1188-1194; doi:10.2337/diabetes.37.9.1188

  3. Tani, S

    • Secretin-induced exocrine secretion in perfused pancreas isolated from diabetic rats. Diabetes September 1988 37:1173-1180; doi:10.2337/diabetes.37.9.1173

  4. Tappy, L

    • Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes September 1988 37:1212-1216; doi:10.2337/diabetes.37.9.1212

  5. Taskinen, M R

    • Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia. Diabetes September 1988 37:1271-1278; doi:10.2337/diabetes.37.9.1271

  6. Thivolet, C H

    • Structure, function, and immunogenicity of human insulinoma cells. Diabetes September 1988 37:1279-1286; doi:10.2337/diabetes.37.9.1279

  7. Tillil, H

    • Reevaluation of urine C-peptide as measure of insulin secretion. Diabetes September 1988 37:1195-1201; doi:10.2337/diabetes.37.9.1195

  8. Torella, R

    • Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent. Diabetes September 1988 37:1265-1270; doi:10.2337/diabetes.37.9.1265

  9. Toyota, T

    • Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes September 1988 37:1188-1194; doi:10.2337/diabetes.37.9.1188

V

  1. Van der Vliet, J A

    • Long-term follow-up of polyneuropathy in diabetic kidney transplant recipients. Diabetes September 1988 37:1247-1252; doi:10.2337/diabetes.37.9.1247

W

  1. Walker, R

    • Distinct macrophage subpopulations in pancreas of prediabetic BB/E rats. Possible role for macrophages in pathogenesis of IDDM. Diabetes September 1988 37:1301-1304; doi:10.2337/diabetes.37.9.1301

  2. Welsh, N

    • Insulin production and glucose metabolism in isolated pancreatic islets of rats with NIDDM. Diabetes September 1988 37:1226-1233; doi:10.2337/diabetes.37.9.1226

  3. Wong, K Y

    • Sequence and analysis of promoter region of human insulin-receptor gene. Diabetes September 1988 37:1241-1246; doi:10.2337/diabetes.37.9.1241

Y

  1. Yki-Järvinen, H

    • Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia. Diabetes September 1988 37:1271-1278; doi:10.2337/diabetes.37.9.1271

  2. Yoon, J W

    • Genetic control of organ-reactive autoantibody production in mice by obesity (ob) diabetes (db) genes. Diabetes September 1988 37:1287-1293; doi:10.2337/diabetes.37.9.1287

Z

  1. Zawalich, K C

    • Phosphoinositide hydrolysis and insulin release from isolated perifused rat islets. Studies with glucose. Diabetes September 1988 37:1294-1300; doi:10.2337/diabetes.37.9.1294

  2. Zawalich, W S

    • Phosphoinositide hydrolysis and insulin release from isolated perifused rat islets. Studies with glucose. Diabetes September 1988 37:1294-1300; doi:10.2337/diabetes.37.9.1294

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement